Pathological outcomes of men eligible for active surveillance after undergoing radical prostatectomy: Are results predictable?

Clinical Genitourinary Cancer

Volumn 10, Issue 1, 2012, Pages 32-36

  Behbahani, Turang Ed ^a   Ellinger, Jrg ^a   Caratozzolo, Daniel Garcia ^a   Mller, Stefan C ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Active surveillance; Partin tables; Pathological outcomes; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; COMPARATIVE STUDY; DISEASE SURVEILLANCE; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PREOPERATIVE EVALUATION; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SEMINAL VESICLE;

ADULT; AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NOMOGRAMS; POPULATION SURVEILLANCE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84857207476     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2011.09.004     Document Type: Article

References (13)

1. F.H. Schroder, J. Hugosson, M.J. Roobol Screening and prostate cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
2. M.R. Cooperberg, J.M. Broering, P.R. Carroll Contemporary trends in low risk prostate cancer: risk assessment and treatment J Urol 178 3 Pt 2 2007 S14 S19
3. R.M. Martin, D. Gunnell, F. Hamdy Conitnuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era J Urol 176 2006 439 449 (Pubitemid 43927893)
4. G.L. Andriole, R.L. Grubb III, S.S. Buys Mortality results from a randomized prostate cancer screening trial N Engl J Med 360 2009 1310 1319
5. G. Ploussard, L. Salomon, E. Xylinas Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance-Does the risk of misclassification vary according to biopsy criteria? J Urol 183 2 2010 539 544
6. R.K. Berglund, T.A. Masterson, K.C. Vora Pathological upgrading and upstaging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964 1968
7. M.A. Dall'Era, J.E. Cowan, J. Simko Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment BJU Int 107 2011 338
8. K. Fujika, P. Landis, B.K. McNeil Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance J Urol 182 2009 2664 2669
9. J. Bresee, P. Spuma, M. Lipsky What is the "true" incidence of active surveillance and brachytherapy candidates in men undergoing robot-assisted radical prostatectomy? J Endourol 24 2010 1671 1674
10. R. Mufarrij, A. Sankin, G. Guilherme Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy Urology 76 2010 689 692
11. I.S. Oliviera, J. Pontes-Junior, D.K. Abe Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy Int Braz J Urol 36 2010 292 299
12. A.S. Duffield, T.K. Lee, H. Miyamoto Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274 2279
13. A.E. Ross, S. Loeb, P. Landis Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program J Clin Oncol 28 2010 2810 2816